A recent study also identified an association of a splice variant in HSD17B13 (rs72613567:TA insertion) with reduced risk of NAFLD (p = 1.3 × 10− 5) [48]. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.